SEC Form 4 · accession 0001487371-15-000044
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gleeson
Officer — SVP, North American Com. Ops.
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2015 | S | 6,105 | $12.06 | D | 187,253 | D | |
| Common Stock | Mar 10, 2015 | S | 516 | $11.84 | D | 186,737 | D | |
| Common Stock | Mar 11, 2015 | S | 3,400 | $11.71 | D | 183,337 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock awards and/or units.